International Registry for Mechanically Assisted Circulatory Support (IMACS)


 
IMACS logo The International Society for Heart and Lung Transplantation Registry for Mechanically Assisted Circulatory Support (IMACS) is an international registry intended to enroll and follow patients who receive durable mechanically assisted circulatory support devices (MCSD) in all countries and hospitals that wish to participate. Durable devices are defined as those devices that are capable of allowing patient discharge with the device in place. Devices are defined on a country by country basis. The registry will record pre-implant patient information, device information and will track the major post implant clinical events.

ISHLT has awarded a three year contract to the Division of Cardiothoracic Surgery at the University of Alabama at Birmingham (UAB) under the direction of Dr. James K. Kirklin. UAB will serve as the data coordinating and analysis center (DCAC). The programming for the web-based data entry system will be performed by the Transplant Informatics Institute (TII), in Richmond, Virginia under a subcontract to UAB. TII is a subsidiary of the United Network for Organ Sharing (UNOS), which is the contractor for the United States Government’s Organ Procurement and Transplantation Network.

 
Benefits to Centers
  • Statistical summaries of hospital experience
  • Benchmarks for comparison against the international experience
  • Description of performance standards for units and practitioners
  • Determine resources (personnel, skills, training) needed to meet performance standards
  • Participate in device research
  • Generate volume and trend data to facilitate short and long term financial planning
     
Benefits to ISHLT
  • Own and direct an international high quality MCSD registry
  • Complement the ISHLT transplant registry as ISHLT emphasizes its role in MCSD research
  • Provides Statistical Reports and Research Analyses to ISHLT Researchers
     
Benefits to MCS Community
  • Improved outcomes from new techniques and devices
  • Facilitate accelerated evaluation of new devices
  • Development of international standards for MCS therapy

See Also: Research Oversight Committee
 

Below are the Steering Committee Members who manage the IMACS Registry

Click on any card below to enlarge for more information. Only ISHLT Members who are logged in can view contact information on the enlarged card.
 
Daniel Goldstein MD

Chair

Montefiore Med Ctr
Bronx, New York, United States
Jennifer Cowger MD, MS

Vice Chair for Data Studies

Henry Ford Hospitals
Detroit, Michigan, United States
Bart Meyns MD, PhD

EUROMACS Representative

UZ Leuven
Leuven, Belgium
Takeshi Nakatani MD, PhD

JMACS Representative

Maki Hosp / MAKI Hlth Care Gr
Osaka-Shi, Osaka, Japan
Steve Shaw

UK Representative


Knutsford, United Kingdom
Amanda Rowe

ISHLT Executive Director

ISHLT Headquarters
Addison, Texas, United States
Rongbing Xie DrPH, MPH

Biostatistician

IMACS
Birmingham, Alabama, United States